These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18783390)

  • 1. Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist.
    Meads DM; McKenna SP; Bonney MA; Bloch MT
    Value Health; 2009; 12(2):397-400. PubMed ID: 18783390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire.
    Doward LC; McKenna SP; Meads DM; Kahler K; Frech F
    Value Health; 2009; 12(1):139-45. PubMed ID: 18647252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
    Bartlett BL; Tyring SK; Fife K; Gnann JW; Hadala JT; Kianifard F; Berber E
    J Clin Virol; 2008 Oct; 43(2):190-5. PubMed ID: 18621575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring health-related quality of life in persons with genital herpes.
    Wild D; Patrick D; Johnson E; Berzon R; Wald A
    Qual Life Res; 1995 Dec; 4(6):532-9. PubMed ID: 8556013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the genital herpes treatment satisfaction questionnaire (GHerpTSQ) in status and change versions.
    Taback NA; Bradley C
    Qual Life Res; 2006 Aug; 15(6):1043-52. PubMed ID: 16900284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
    Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
    Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-day famciclovir therapy for recurrent genital herpes.
    Whitley R; Diaz-Mitoma F; Hamed K
    Curr Med Res Opin; 2006 Jul; 22(7):1307-10. PubMed ID: 16834829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.
    Doward LC; McKenna SP; Kohlmann T; Niero M; Patrick D; Spencer B; Thorsen H
    Qual Life Res; 1998 Feb; 7(2):143-53. PubMed ID: 9523496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Famciclovir in the treatment of family herpes].
    Kniaz'kin IV; Zeliugin PN; Smorchkov AA; Filipov SV; Voskresenskiĭ DA
    Urologiia; 2004; (4):41-3. PubMed ID: 15457953
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis.
    de la Loge C; Sullivan K; Pinkney R; Marquis P; Roux C; Meunier PJ
    Health Qual Life Outcomes; 2005 Nov; 3():69. PubMed ID: 16283929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation, cultural adaptation, and Rasch analysis of the visual function (VF-14) questionnaire.
    Khadka J; Huang J; Mollazadegan K; Gao R; Chen H; Zhang S; Wang Q; Pesudovs K
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4413-20. PubMed ID: 24917139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital herpes simplex virus and its treatment: focus on famciclovir.
    Sacks SL
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):32-6. PubMed ID: 8840414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent genital herpes and quality of life in France.
    Spencer B; Leplège A; Ecosse E
    Qual Life Res; 1999 Jun; 8(4):365-71. PubMed ID: 10472169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famciclovir effective in suppressing recurrent genital herpes.
    AIDS Patient Care STDS; 1996 Apr; 10(2):130. PubMed ID: 11361692
    [No Abstract]   [Full Text] [Related]  

  • 19. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
    Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
    J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries.
    Virués-Ortega J; Carod-Artal FJ; Serrano-Dueñas M; Ruiz-Galeano G; Meza-Rojas G; Velázquez C; Micheli F; Martínez-Martín P
    Value Health; 2009; 12(2):385-91. PubMed ID: 18657094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.